NanoSphere Health Sciences Inc. to Webcast, Live, at VirtualInvestorConferences.com January 18
Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com
DENVER, Jan. 17, 2018 /CNW/ -- NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) (the "Company"), based in Denver, focused on nutraceuticals & supplements, cannabis, pharmaceuticals, OTCs, cosmetics, and animal health products, today announced that Victor Goncalves, Executive Vice President, and Dr. Richard Kaufman, Chief Science Officer, will present live at VirtualInvestorConferences.com on January 18, 2018 at 1:30pm Eastern.
DATE: Thursday January 18, 2018
TIME: 1:30 PM Eastern
LINK: https://tinyurl.com/0118prepr
This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the association's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.
It is recommended that investors pre-register and run the online system check to save time and receive event updates.
Learn more about the event at www.VirtualInvestorConferences.com.
Recent Company Highlights
- January 2018: NanoSphere Health Science, LLC is nominated for NCIA's Excellence in Technology Award
- November/December 2017: NanoSphere Health Sciences Inc. (CSE: NSHS) (formerly Corazon Gold Corp.) completes acquisition of NanoSphere Health Sciences, LLC, $6.0m financing, name change, and listing on the Canadian Securities Exchange.
About NanoSphere Health Sciences
NanoSphere Health Sciences Inc., through its wholly owned operating subsidiary, NanoSphere Health Sciences, LLC, is a biotechnology company commercializing the NanoSphere Delivery System™, a revolutionary platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries, and beyond. The patent-pending NanoSphere Delivery System™ represents one of the most important developments for advancing the non-invasive and user-friendly delivery of biological agents in over 25 years. For more information on NanoSphere, please visit http://www.nanospherehealth.com.
About VirtualInvestorConferences.com
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
Forward Looking Statement Caution
This news release includes forward looking statements that are subject to assumptions, risks and uncertainties. Statements in this news release which are not purely historical are forward looking statements, including without limitation any statements concerning the Company's intentions, plans, estimates, expectations or beliefs regarding the future. Although the Company believes that any forward looking statements in this news release are reasonable, there can be no assurance that any such forward looking statements will prove to be accurate. The Company cautions readers that all forward looking statements, including without limitation those relating to the Company's future operations and business prospects, are based on assumptions none of which can be assured, and are subject to certain risks and uncertainties that could cause actual events or results to differ materially from those indicated in the forward looking statements. Readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance on forward looking statements. Any forward looking statements are made as of the date of this news release, and the Company assumes no obligation to update the forward looking statements, or to update the reasons why actual events or results could or do differ from those projected in the forward looking statements, whether as a result of new information, future events or otherwise.
SOURCE NanoSphere Health Sciences Inc.
PR Contact: Kate Wells, Chief Marketing Officer, Direct: 720-528-4437, Mobile: 303-324-7358, E-mail: [email protected], Investor Contact: Victor Goncalves, Executive Vice President, Mobile: 204-997-5517, E-mail: [email protected], VirtualInvestorConferences.com, John Viglotti, VP, Investor Relations Products and Services, Cision / PR Newswire / MultiVu, +1.201.360.6767, [email protected], http://www.nanospherehealth.com
Share this article